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ABSTRACT 
The histone acetyltransferase protein, Tip60, has many important functions in epigenetic 
regulation of gene expression and DNA repair. Our objective is to design, synthesize, and evalu-
ate potent inhibitors for Tip60. Full-length Tip60 (fl-Tip60) and catalytic domain of Tip60 (cat-
Tip60) were expressed in E. coli and purified with nickel affinity chromatography. Quantitative 
analysis of enzyme activities demonstrated that both enzyme forms had very high activity with 
the substrate H4. To create new Tip60 inhibitors, various histone H3 peptides conjugated with 
CoA were synthesized using the Fmoc solid-phase peptide synthesis and solution phase synthesis 
protocols. The results from the inhibition radioactive assay showed that the synthetic H3-CoA 
conjugates inhibited effectively the enzymatic activity of both fl-Tip60 and cat-Tip60; and the 
addition of methyl groups to the Lys-4 or Lys-9 residue of H3 aided in a 7-9 fold enhancement in 
potency in comparison to nascent H3-CoA inhibitor. 
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1 INTRODUCTION  
The field of epigenetics is growing rapidly in biology due to the huge impact that it has 
on life, disease and new therapies. Epigenetics deals with the phenotypic cellular changes with-
out any changes in the genotypic sequence [1]. Histone acetyltransferase (HAT) proteins are en-
zymes that play important roles in epigenetic regulation of gene function. The HAT family has 
several subfamilies, categorize by their sequence similarity which includes GNAT family 
(GCN5, PCAF (p300 cyclic AMP-responsive element binding protein associated factor)), the 
MYST (MOZ, Ybf2/Sas3, Sas2, Tip60), and the p300/CBP family [2, 3]. The MYST protein 
family which contains the 60-kDa HIV Tat-Interacting protein (Tip60) is responsible for many 
biological processes including gene regulation, cell signaling, DNA damage repair and tumori-
genesis [4].  
1.1 The histone acetyltransferase Tip60 
Tip60, the protein of interest, is composed of two very important domains, the chromo-
domain and the catalytic domain (Figure 1-1). The chromodomain region of this enzyme consists 
of conserved hydrophobic amino acids that may interact with the methyl groups on specific ly-
sine residue [5]. In vivo methylated lysine residues are a result of enzymatic reaction of methyl-
transferase and are thought to have specialized roles in biological functions [6]. The function of 
the catalytic domain Tip60 is to catalyze the transfer of an acetyl group from acetyl-CoA to spe-
cific lysine amino acids on the N-terminal tails of the nucleosomal core histones [7]. In vitro, the 
core histones targeted for acetylation by Tip60 are H2A (Lys5), H3 (Lys14), H4 (Lys5, Lys8, 
Lys12, and Lys16) [8]. An important part of the catalytic domain that is required for protein-
protein interactions and acetyltransferase activity is the Cys-Cys-His-Cys zinc finger [9]. Lysine 
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acetylation has many effects on protein functions, including DNA binding, protein-protein inter-
actions and possibly stability regulation [4]. It can also disrupt the charge on the histones, by 
neutralizing the charge on the lysine residue, which will decrease the affinity of the DNA leading 
to open chromatin [10]. Open chromatin is prone to attracting transcription factors to bind and 
transcribe unwanted genes causing diseases, such as cancer [7]. 
 
Figure 1-1: Domain structures of Tip60. The N-terminal of this enzyme contains the chromo-
domain and the C-terminal contains the catalytic MYST domain [4]. 
 
1.2 Diseases linked to deregulation of Tip60 
Tip60 has the ability to acetylate lysine residues on histone as well as nonhistone pro-
teins, and the deregulation of this enzyme has been observed in many diseases such as prostate 
cancer, and Alzheimer’s disease. The lysine residues on the hinge region of the androgen recep-
tors are an example of a nonhistone proteins that can be acetylated by Tip60 [10]. High levels of 
Tip60 acetylation activity can cause the proliferation of androgen receptors which can aid in the 
progression of prostate cancer [10, 11]. In Alzheimer’s disease, Tip60 forms a regulatory com-
plex with amyloid precursor protein intracellular domain [12, 13]. It is thought that this complex 
is then able to regulate the transcription of genes responsible for the neurogenesis by acetylating 
certain histone proteins [13]. Tip60 not only causes cancer but can also block cancer therapeutic 
treatments such as ionizing radiation due to its role in DNA damage repair. Blocking such treat-
ment will aid in the further advancement of the cancer [10]. Given Tip60’s ability to promote 
and advance detrimental diseases, it is important to study this enzyme to better understand the 
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roles of domain function in activity regulation and to design novel strategies for enzyme inhibi-
tion.   
1.3 Previously reported inhibitors for Tip60 
Previous inhibitors for HAT enzymes have been synthesized and reported by our group 
and others [7, 10, 14, 15]. Inhibitors targeting Tip60 include small molecule inhibitors as well as 
histone H3 and H4 peptide-CoA bisubstrate inhibitors [7, 15]. The bisubstrate inhibitors were 
synthesized with a CoA linked to the lysine actylation site specific for Tip60. It was reported that 
of all the inhibitors, H4K16CoA was observed to be the strongest inhibitor for Tip60. Notably, it 
was also determined that the bisubstrate inhibitors had a greater inhibition for all of the HAT en-
zymes tested in comparison to anacardic acid and curcumin [15].  
1.4 Objective of this study  
We previously reported that histone peptides conjugated with CoA is a good bisubstrate 
inhibitor for Tip60. Herein, we attempt to further improve the potency of this type of inhibitors 
by introducing new binding motifs. Literature studies have reported that the chromodomain of 
Tip60 has a high binding affinity for specific methylated lysine residues on H3 peptides such as 
H3K4Me and H3K9Me3 [5, 16]. Based on those studies, we propose to design improved bisub-
strate inhibitors with the rationality that the methylated marker at specific lysine residue would 
bind to the other domain motifs (e.g. chromodomain), and the CoA would bind to the catalytic 
site to create an even stronger inhibition of Tip60 (Figure 1-2).  
In this study we explore the enzymatic difference between the full length Tip60 (fl-Tip60, 
61116.91 Da) and the region of Tip60 protein that contains only the catalytic domain (cat-Tip60, 
36983.61 Da), as well as, the design of substrate-based Tip60 inhibitors. In comparing the activ-
ity of fl-Tip60 versus cat-Tip60 as well as their inhibition by various H3-CoA conjugates, insight 
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into the importance of the chromodomain in Tip60 inhibition could be gained. To determine the 
potency of the inhibitors in the presence of Tip60, protein expression and purification will be 
done first, followed by filter binding activity radioactive assay and inhibition radioactive study. 
The filter binding radioactive inhibition assay will also be done on another HAT enzyme, PCAF, 
to test the potency of the inhibitors on other HAT paralogs, which offers information about the 
specificity of the designed Tip60 inhibitors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-2: Cartoon model of Tip60 enzyme and H3-CoA inhibitor. It was 
thought that the chromodomain and catalytic domain of the Tip60 enzyme will bind 
to the methyl groups and the CoA on the H3 peptide respectively, to create a 
stronger inhibition for Tip60.  
CoAMe3
K14K9
H3(1-20)
Me
K4
Tip60
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2 METHODS 
2.1 Inhibitor synthesis, purification, and characterization 
Various peptides containing the first 20 amino acids of the N-terminal of Histone 
H3(acARTKQTARKSTGGKAPRKQL) were synthesized on a PS3 peptide synthesizer using 
the Fmoc [N-(9-fluorenyl) methoxycarbonyl] -based solid-phase peptide synthesis protocols. The 
amino acids and Leu Wang resin was weighed out with an equivalence ratio four times greater 
than the amount of HCTU [O-(1H-6-Chlorobenzotriazole-1-yl)-1,1,3,3-tetramethyluronium hex-
afluorophosphate] coupling reagent. The Dde group (dimethyldioxocyclohexylidene) on Lys-14 
was cleaved using 65% hydrazine monohydrate. Next, bromoacetic acid was added in addition to 
DIC (N, N'-diisopropylcarbodiimide) and DMF (dimethylflormamide) to create a bromoacetyl 
linker which was used to add on a CoA to the peptide. Before the CoA was added, the resin was 
cleaved using TFA (trifluoroacetic acid). The peptide was then purified using reversed phase 
HPLC (High-performance liquid chromatography), flash frozen and lyophilized. To determine if 
the peptide of interest was present, a small amount of each sample was dissolved in about 10µl 
of ddH2O and was sent off to obtain a mass spectra. Concentrations for compounds not contain-
ing CoA were determined based off of the weight. The concentrations of the peptides containing 
CoA was done by making serial dilutions of the compound and measuring the absorbance at 
260nm. Lastly, 1M NaCl was used to neutralize the pH (Figure 2-1). 
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Figure 2-1: Steps in the Fmoc-based solid-phase peptide synthesis protocol. These steps 
were used to synthesize the H3 peptide inhibitors 
 
2.2 Protein expression  
Both enzymes forms of Tip60, fl-Tip60 and cat-Tip60, in addition with PCAF was ex-
pressed using the His 6x tagged protein expression protocol. The antibiotic used for both fl-
Tip60 and cat-Tip60 was ampicillin and the antibiotic used for PCAF was kanamycin. Transfor-
mation was done by heat shock using Escherichia coli Bl21 (DE3) competent cells. The cells 
were then spread on the respective antibiotic treated plates and incubated at 37°C. Colonies were 
then harvested and grown in 8mL then in 2 L cultures both containing LB media and proper an-
tibiotic at 37°C. To induce protein expression in the liter cultures, 1M IPTG (isopropyl β-D-1-
thiogalactopyranoside) was added at 16°C and cultures were shaken overnight. Inoculated media 
was centrifuged and harvested cells were dissolved in lysis buffer (25 mM Na-HEPES pH:8, 150 
mM NaCl, 1mM MgSO4, 5% glycerol, 5% ethylene glycol, and 1 mM PMSF) and French 
9 
pressed. After the French press process, the lysed cells were centrifuged. Chromatography col-
umns containing Ni-NTA beads were used to purify the supernatant after first being equilibrated 
with 1x column equilibrium buffer (25mM Na-HEPES pH:8, 500mM NaCl, 30mM imidazole, 
10% glycerol and 1mM PMSF). The supernatant from the centrifuged sample was added to the 
column and incubated for 1hour at 4°C. The column was re-equilibrated with equilibrium buffer. 
Next, the column was washed with column washing buffer (25mM Na-HEPES pH:8, 300mM 
NaCl, 70mM imidazole, 10% glycerol, and 1mM PMSF) and the protein was eluted using elu-
tion buffer (25mM Na-HEPES pH:8, 300mM NaCl, 100mM EDTA, 200mM imidazole, 10% 
glycerol, and 1mM PMSF). After the collected protein was dialyzed in dialysis buffer (25mM 
Na-HEPES pH: 7, 300mM NaCl, 1mM EDTA, and 10% glycerol), it was concentrated. A 12% 
SDS-PAGE was done to ensure the desired protein was present and a Bradford assay was com-
pleted to calculate the protein concentration (Equation 1). Lastly the protein was aliquoted, flash 
frozen, and stored in the -80°C freezer.  
 
(Average OD of Samples/ Average OD of Standard) *2 Concentration  = 
Molecular Weight of Protein  
 
Equation 1: This equation was used to determine the concentration of the protein  
 
2.3 Radioactive filter binding assays 
2.3.1 Determining the suitable substrate for fl-Tip60 and cat-Tip60 
To find a suitable substrate for fl-Tip60 and cat-Tip60, the acetylation activity of both 
enzymes was measured. Mixture A containing 10µΜ of   14C labeled acetyl coenzyme A (14C-
AcCoA), reaction buffer (50 mM HEPES (pH 8.0), 0.1 mM EDTA) and double deionized water 
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(ddH2O) was incubated at 30°C with 200µM of various peptides (H3K4Me, H3K9Me3, H3-20 
and H4-20). After, 5min the 0.2 µM of the enzyme was added and the samples were incubated 
again at 30°. At various times (3, 5, 10 minutes) the reaction was spread on the charged What-
man P81 filter paper to quench the reaction. The filter papers were dried for 30 min and washed 
with 50 mM NaHCO3 buffer (pH: 9) three times, 15 min each time. Scintillation cocktail was 
added to each of the re-dried filer papers which were then quantified using the Beckman scintil-
lation counter. Each assay for every substrate was repeated twice. The data collected from these 
assays were graph with the coordinates containing average product (µM) vs. time (min) and the 
linear slope was used to determine the rates for each substrate (Figure 2-2).    
2.3.2 Efficiency analysis of fl-Tip60, cat-Tip60, and PCAF 
The kinetics of fl-Tip60, cat-Tip60, and PCAF was determined by first preparing mixture 
A containing 10µΜ of 14C-AcCoA, 4x running buffer (50 mM HEPES (pH 8.0), 0.1 mM ED-
TA), and ddH2O. The substrates were incubated with the running mixture at 30°C. After, 5min 
the enzyme (fl-Tip60, 0.1 µM; cat-Tip60, 0.1 µM; PCAF, 2-5nM) was added and the samples 
were incubated again for another 6-10 minutes at 30° C. The reaction was spread on the What-
man P81 filter paper to quench the reaction. The filter papers were left to dry for 30min, then 
washed tree times with 50 mM NaHCO3 buffer (pH:9) for 15min each time. The filter papers 
were re-dried and liquid scintillation oil was added and the samples were quantified using the 
Beckman scintillation counter. Each assay was repeated twice and the data collected from these 
assays were fitted to the Michaelis Menten equation to determine efficiency of flTip60 and cat-
Tip60 (Figure 2-2).  
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2.3.3 Radioactive Inhibition Assay 
The potency of the inhibitors was determined by the filter binding assay. This assay was 
started by first preparing the buffer B containing 1µΜ of 14C-AcCoA, reaction buffer (50 mM 
HEPES (pH 8.0), 0.1 mM EDTA), 100 µΜ of H4-20 and ddH2O. The inhibitors were incubated 
with the running mixture at 30°C. After, 5min either the enzyme (fl-Tip60, 0.01-0.04 µM; cat-
Tip60, 0.04-0.067 µM; PCAF, 2-5nM) was added and the samples were incubated again for 10 at 
30°C. The reaction was spread on the charged Whatman P81 filter paper to quench the reaction. 
The filter papers were left to dry for 30min, then washed tree times with 50 mM NaHCO3 buffer 
(pH:9) for 15min each time. The filter papers were re-dried and liquid scintillation oil was added. 
The samples were quantified using the Beckman scintillation counter. Lastly, the data was ana-
lyzed on Kaleida Graph software and fitted to the Langmuir isotherm equation (Equation2). Each 
assay for every inhibitor was repeated at least two times (Figure 2-2). 
 
1 Fractional activity = 
[ I ] 
   
1+ 
IC50 
 
Equation 2: Langmuir isotherm equation: This equation was used to fit data and obtain Ic50 
values  
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Figure 2-2: Steps for the radioactive filter binding assay. These steps were taken to determine 
the acetylation activity, kinetic parameters and IC50 for both fl-Tip60 and cat-Tip60. 
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3 RESULTS AND DISCUSSION  
3.1 Expression of fl-Tip60, cat-Tip60, and PCAF 
The DNA sequences encoding each protein sequence was inserted into an expression vec-
tor, Tip60 in the pET21a vector and PCAF in the pET28a vector. Included in sequence was the 
His tag at the C-terminal for both full-length Tip60 (fl-Tip60) and catalytic domain of Tip60 
(cat-Tip60), and at the N-terminal for PCAF (Sequence 1, 2, & 3). These vectors, containing the 
desired protein sequence, were expressed in E. coli and purified with nickel affinity chromatog-
raphy. To determine whether the proteins of interest were present, certain samples were taken 
during the purification steps and ran through a 12% SDS-PAGE (Sodium dodecyl sulfate poly-
acrylamide gel electrophoresis). Based on the bands present around 60kDa, 36kDa, and 21kDa in 
each of the SDS-PAGE, it was determined that the proteins of interest, fl-Tip60, cat-Tip60 and 
PCAF was present respectively (Figure 3-1, 2, 3).  
Sequence 1: Amino Acid Sequence of flTip60: The red part is from vector and His tag and 
the black is the sequence of fl-Tip60 
MASMTGGQQMGRGSEFMAEVGEIIEGCRLPVLRRNQDNEDEWPLAEILSVKDISGRKLF
YVHYIDFNKRLDEWVTHERLDLKKIQFPKKEAKTPTKNGLPGSRPGSPEREVPASAQAS
GKTLPIPVQITLRFNLPKEREAIPGGEPDQPLSSSSCLQPNHRSTKRKVEVVSPATPVPSET
APASVFPQNGAARRAVAAQPGRKRKSNCLGTDEDSQDSSDGIPSAPRMTGSLVSDRSHD
DIVTRMKNIECIELGRHRLKPWYFSPYPQELTTLPVLYLCEFCLKYGRSLKCLQRHLTKC
DLRHPPGNEIYRKGTISFFEIDGRKNKSYSQNLCLLAKCFLDHKTLYYDTDPFLFYVMTE
YDCKGFHIVGYFSKEKESTEDYNVACILTLPPYQRRGYGKLLIEFSYELSKVEGKTGTPE
KPLSDLGLLSYRSYWSQTILEILMGLKSESGERPQITINEISEITSIKKEDVISTLQYLNLINY
YKGQYILTLSEDIVDGHERAMLKRLLRIDSKCLHFTPKDWSKRGKLEHHHHHH 
 
Sequence 2: Amino Acid Sequence of cat-Tip60: The red part is from vector and His tag 
and the black is the sequence of cat-Tip60 
MASMTGGQQMGRGSEFSHDDIVTRMKNIECIELGRHRLKPWYFSPYPQELTTLPVLYLC
EFCLKYGRSLKCLQRHLTKCDLRHPPGNEIYRKGTISFFEIDGRKNKSYSQNLCLLAKCF
LDHKTLYYDTDPFLFYVMTEYDCKGFHIVGYFSKEKESTEDYNVACILTLPPYQRRGYG
KLLIEFSYELSKVEGKTGTPEKPLSDLGLLSYRSYWSQTILEILMGLKSESGERPQITINEIS
EITSIKKEDVISTLQYLNLINYYKGQYILTLSEDIVDGHERAMLKRLLRIDSKCLHFTPKD
WSKRGKLEHHHHHH 
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Sequence 3: Amino Acid Sequence of PCAF: The red part is from vector and His tag and 
the black is the sequence of the catalytic domain of PCAF 
GSSHHHHHHSSGLVPRGSHMAS-
VIEFHVVGNSLNQKPNKKILMWLVGLQNVFSHQLPRMPKEYITRLVFDPKHKTLA-
LIKDGRVIGGICFRMFPSQGFTEIVFCAVTSNEQVKGYGTHLMNHLKEYHIKH-
DILNFLTYADEYAIGYFKKQGFSKEIKIPKTKYVGYIKDYEGATLMGCELNPRIPYTE 
 
 
 
Figure 3-1: 12% SDS-PAGE with the samples from fl-Tip60 purification. From this gel the 
bands indicate that the desired FL-Tip60 protein (M.W: 61,116.91 Da) is present . 
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Figure 3-2: 12% SDS-PAGE with the samples from cat-Tip60 purification. From this gel the 
bands indicate that the desired protein, cat-Tip 60, (M.W: 36,694Da) is present in the sample. 
 
 
 
Figure 3-3: 12% SDS-PAGE with the samples from PCAF purification. From this gel the 
bands indicate that the desired PCAF enzyme (M.W: 21,479.95 Da) is present in the sample. 
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3.2 Suitable substrate for fl-Tip60 and cat-Tip60  
To find the most suitable substrate for Tip60, radioactive filter binding assays was carried 
out using both cat-Tip60 and fl-Tip60. For theses assays, 14C-AcCoA provided the radioactive 
acetyl group that would be transferred to the various substrates. The data collected from these 
assays were graphed with the coordinates containing average product (µM) vs. time (min). The 
slope from the linear equation used determined the rates for each of the substrate. An example of 
this graph is shown in Figure 3-4 (Graphs for other substrate in Appendix B). 
Finding substrates that both enzymes had high affinity for was important for future radio-
active inhibition studies. For this radioactive filter binding assay, it was observed that both fl-
Tip60 and cat-Tip60 had a high rate of product production with H4(1-20) peptide as its substrate. 
Fl-Tip60 had a 3-7 fold increase in the enzymatic rate production with H4(1-20) as its substrate 
in comparison to the methylated and non-methylated H3(1-20) peptides. Similarly, cat-Tip60 had 
a 2-6 fold increase with H4(1-20) as its substrate when compared to the methylated and non-
methylated H3(1-20) peptides. Based on this assay it was determined that H4(1-20) would be the 
appropriate substrate for the future radioactive filter binding inhibition assay (Figure 3-5). It is 
possible that H4(1-20) has a higher activity because naturally Tip60 can acetylate more lysine 
residues on this histone peptide (Lys5, Lys8, Lys12, and Lys16). Whereas for H3(1-20), Tip60 
can only acetylate one lysine residue (lys14). 
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Figure 3-5: Summarized data graph of Tip60 activity for different peptide substrates. This 
graph shows that the H4(1-20) substrate has a higher affinity for both fl-Tip60 and cat-Tip-60. The 
final concentration for substrates, 200µM; enzyme, 0.2µM; 14C-AcCoA, 10 µM; and reaction time 
3, 5, 10 minutes    
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Figure 3-4: Activity of cat-Tip60 for H3-20 acetylation. Reaction conditions include: H3-20, 
200µM; enzyme, 0.2µM; 14C-AcCoA, 10 µM; and reaction time 3, 5, 10 minutes    
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3.3 Synthesis of various H3 peptide compounds  
Solution phase organic synthesis and Fmoc-based solid phase peptide synthesis methodol-
ogy was used to synthesize the various H3 peptide-CoA conjugates. A few of these H3-CoA 
compounds (H3K4MeK14CoA, H3K4Me, H3K9Me3K14CoA, H3K9Me3 and 
H3K9Me3K14Sme) were synthesized by some other members in Dr. Zheng’s laboratory. All the 
synthetic compounds were purified by reverse phase HPLC and confirmed by mass spectrome-
try. (The mass spectra of the peptides synthesized are shown in Appendix A.) The structural se-
quence and desired molecular weight of all the bisubstrate compounds are summarized in Table 
1. 
Table 1: The design and synthesis of various H3-CoA conjugate inhibitors: The sequence of 
each peptide is provided along with the calculated molecular weight and the molecular weight 
measured from the mass spectra of each sample. 
 
Compound Name Sequence MW 
calc. 
MW meas-
ured 
H3(1-20)K14CoA ARTKQTARKSTGGK(CoA)APRKQL 3034.8 3034.2 
H3(1-20)K9me3K14CoA ART-
KQTARK(Me)3STGGK(CoA)APRKQL 
3075.9 3075.3 
H3(1-20)K4me1K14CoA ARTK(Me)QTARKSTGGK(CoA)APRKQ
L 
3048.1 3047.3 
H3(1-
20)K4me1K9me3K14CoA 
ARTK(Me)QTARK(Me)3STGGK(CoA)A
PRKQL 
3089.2 3089.4 
H3(1-20)K14sme ARTKQTARKSTGGK(SMe)APRKQL 2313.6 2347.0 
H3(1-20)K9me3K14sme ART-
KQTARK(Me)3STGGK(SMe)APRKQL 
2355.6 2355.4 
H3K14Br ARTKQTARKSTGGK(Br)APRKQL 2348.5 2348.4 
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H3K4MeK14Br ARTKQTARK(Me)STGGK(Br)APRKQL 2361.6 2361.4 
 
3.4 Determining the IC50 of various inhibitors for fl-Tip60 and cat-Tip60  
The calculated IC50 value of the inhibitors for fl-Tip60 and the cat-Tip60 was determined 
by fitting the data from the filter binding radioactive inhibition assay to the Langmuir isotherm 
equation. Experimental conditions for this assay included 100 µM of H3(1-20) peptide as the 
substrate; 10 µM of [14C]acetyl-CoA, a reaction time of 5-10 min, 0.01-0.04 µM of fl-Tip60, 
0.04-0.067 µM of cat-Tip60 and a total volume of 30 µL. The data from table 2 shows little dif-
ference between the IC50 values of the various inhibitors for fl-Tip60 compared to cat-Tip60. 
This maybe suggesting that the chromodomain of fl-Tip60 may not be a strong binding site of 
the methyl groups, and that perhaps the methyl binding site may actually be closer to the cata-
lytic site. The IC50 of CoA (fl-Tip60 =9.12 µM and cat-Tip60=16.01 µM) and H3(1-20)K14CoA 
(fl-Tip60 =7.8 µM and cat-Tip60=14.66 µM) is very similar to one another. These results indi-
cate that the addition of CoA to an H3 (1-20) peptide does not change the ability of CoA to in-
hibit Tip60. 
The inhibitor presenting the lowest IC50 is H3K9MeK14CoA (fl-Tip60 =1.16 µM and cat-
Tip60= 1.64 µM) and H3K4MeK14CoA (fl-Tip60 =2.09 µM and cat-Tip60=3.51 µM). In the 
presence of H3K9Me3K14CoA there is about a 7-9 fold decrease in the IC50 value; however, in 
the presence of H3K4MeK14CoA there is about a 4 fold decrease in the IC50 value when com-
pared to the inhibition potency of just CoA. 
Inhibitors displaying no inhibition for Tip60 is H3K14SMe at 250 mM and both H3K14Br 
and H3K4MeK14Br at 500 µM. Since CoA is missing from all of these inhibitors, this data im-
plies that CoA contributes a great deal in the inhibition of Tip60 and that without it the potency 
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of the inhibitor can be lost. However, in the presence of H3K9Me3K14SMe (fl-Tip60 =34.5 µM 
and cat-Tip60= 27.4 µM) there is inhibition. This suggests that the methyl groups at Lys-9 do 
play a role in the inhibition of Tip60, but the addition of CoA is needed for greater inhibition po-
tency. 
Lastly, the inhibitor H3K4MeK9Me3K14CoA (fl-Tip60 =22.22 µM and cat-Tip60= 14.99 
µM) was tested. It seems that the methyl groups at Lys-4 and 9 combined on to the same H3-
CoA conjugate maybe blocking each other and from the binding site which resulted in the de-
crease potency (Table 2).  
3.5 Determining the IC50 of various inhibitors for PCAF  
The IC50 of various inhibitors for PCAF was determined using the same procedure as the 
previous assay except H3-20 was used in place of the substrate in the previous assay, and 2-5 nM 
of PCAF was used. Since H3K14CoA was reported previously to be a good inhibitor for PCAF, 
here we also tested the inhibition of PCAF using various methylated H3 peptides [14]. Of the 
various inhibitors, the most potent inhibitor for PCAF was observed to be H3K9Me3K14CoA 
with an IC50 of 0.28 µM. In comparison to the Lys-9 methylated inhibitor, H3K4MeK14CoA had 
an IC50 of 1.07 µM which is greater by 3folds. Peptides only containing CoA (IC50 of 14.93 µM) 
or a CoA at Lys-14 (IC50 of 19.0 µM) had a 53 and 67 fold increase respectively in IC50 values 
for PCAF in comparison to H3K9Me3K14CoA. Lastly the double methylated inhibitor, 
H3K4MeK9Me3K14CoA, had an IC50 of 3.62 µM.  
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Table 2: IC50 of various inhibitors for cat-Tip60, fl-Tip60 and PCAF. Experimental condi-
tions: substrate,100 µM; [14C]acetyl-CoA, 10 µM; reaction time, 5-10 min; fl-Tip60, 0.01-0.04 
µM; cat-Tip60, 0.04-0.067 µM; PCAF, 2-5nM; total volume, 30µL.  
 IC50 for 
fl-Tip60 (µM) 
IC50 for 
cat-Tip60 (µM) 
IC50 for 
PCAF (µM) 
H3(1-20)K14CoA 7.80 ± 1.98 14.66 ± 0.94 19.0 ± 5.50 
H3(1-20)K9me3K14CoA 1.16 ± 0.08 1.64 ± 0.16 0.28 ± 0.06 
H3(1-20)K4me1K14CoA 2.09 ± 0.41 3.51 ± 0.06 1.07 ± 0.13 
H3(1-20)K4me1K9me3K14CoA 22.22 ± 1.19 14.99 ± 1.28 3.62 ± 1.00 
H3(1-20)K14sme No inhibition at 
250 µM 
No inhibition at 
250 µM 
 
______ 
H3(1-20)K9me3K14sme 34.5 ± 2.0 27.4 ± 2.6 ______ 
H3(1-20)K14Br No inhibition at 
500 µM 
No inhibition at 
500 µM 
 
______ 
H3(1-20)K4meK14Br No inhibition at 
500 µM 
No inhibition at 
500 µM 
 
______ 
CoA 9.12 ± 0.98 16.01 ± 3.14 14.93 ± 1.53 
 
3.6 Efficiency of fl-Tip60, cat-Tip60, and PCAF 
The enzyme kinetic data for of fl-Tip60, cat-Tip60, and PCAF was obtained using the ra-
dioactive filter binding assay. Experimental conditions for this assay included 0-2000 µM of the 
substrate; 10 µM of [14C]acetyl-CoA, a reaction time of 5-12 min, 0.1 µM of fl-Tip60, µM; 0.1 
22 
of cat-Tip60, 2-5nM of PCAF, and a total volume of 30µL. The Kcat/Km for both fl-Tip60 and 
cat-Tip60, ranged from 0.001 µM-1/min-1 to 0.007 µM-1/min-1 indicating that enzyme efficiency 
is very poor (Table 3 & 4). However, the values for Kcat/Km are greater for PCAF than the val-
ues for Tip60. It seems that PCAF is most efficient in the presence of H3K9M3 (0.717 µM-1/min-
1) in comparison to H3-20 (0.488 µM-1/min-1) and H3K4Me (0.405 µM-1/min-1) (Table 5). 
 
Table 3: Radioactive assay to determine enzyme efficiency. Experimental conditions: sub-
strate, 0-2000 µM; [14C] acetyl-CoA, 10 µM; fl-Tip60, 0.1 µM; cat-Tip60, 0.1 µM; PCAF, 2-
5nM, reaction time, 5-12 min; total volume, 30 µL; 
Kcat /Km (uM-1/min-1) 
Peptide Fl-Tip60 Cat–Tip60 PCAF 
H3-20 0.00157 0.00141 0.48821 
H3(1-20)K9me3 0.00103 0.00091 0.71711 
H3(1-20)K4me1 0.00729 0.00305 0.40490 
H3(1-20)K4MeK9Me3 0.00147 0.00075 ______ 
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CONCLUSION 
Epigenetics plays a big role in managing how much a gene is expressed as well as which 
genes should (not) be expressed. It is important to further investigate epigenetic enzymes, such 
as Tip60, which has the ability to modify histone and non-histone proteins and cause a wide 
range of diseases. Unregulated Tip60 can hyperactylate proteins and cause diseases such as pros-
tate cancer and Alzheimer’s disease. Due to these life threatening diseases, it is crucial to de-
velop therapeutic potent inhibitors to target Tip60.  
Previous studies have shown that histone H3 and H4 peptide-CoA bisubstrate inhibitors 
display inhibitory effects towards Tip60 [15]. Studies have also reported that the chromodomain 
of Tip60 has a high binding affinity for specific methylated lysine residues on H3 peptides, such 
as H3K4Me and H3K9Me3 [5, 16]. By adding methyl groups to H3 peptide-CoA we attempt to 
further improve the potency of this bisubstrate inhibitor. To start the expression and purification 
of flTip60, cat-Tip60 and PCAF was done with high yields and good purities. Next, the synthesis 
of a series of H3-CoA conjugates was achieved by using the Fmoc peptide synthesis protocol 
and solution phase organic synthesis. Lastly, detailed radioactive filter binding assays were com-
pleted to quantify the enzymatic activity and to determine the IC50 of the synthesized inhibitors. 
Notably, the results from the filter binding radioactive assay indicate that the H4(1-20) 
peptide was the most suitable substrate for both flTip60 and cat-Tip60. Results from the radioac-
tive inhibition assay show that the chromodomain of fl-Tip60 may not be a strong binding site 
for the methyl groups, since there was no significant difference in the IC50 values between the fl-
Tip60 and cat-Tip60 enzyme forms. This also suggests that the methyl binding site may be closer 
to the catalytic site. Furthermore, tri-methylated Lys-9 can inhibit Tip60 without CoA, but for 
24 
enhanced inhibition the addition of the CoA is needed. Lastly, the inhibitor 
H3K4MeK9Me3K14CoA had weaker potencyfor both the Tip60 and PCAF data in comparison 
to the inhibitors with only one methylated site. This suggest that the perhaps the bindinging 
region of the HAT enzyme can only accommodate one methylated group. These results also 
indicate that the effect of themethyl group of these inhibitors are not only specific to Tip60. 
 In the future, more research would be needed to test the binding pocket of the methyl 
groups. It would be interesting to determine whether it is the location of the methyl groups on the 
H3 peptide, or whether it is the number of methyl groups on the lysine residues that would 
contribute to the greatest inhibition. Previous studies have shown that acetylated H3(1-20) 
peptides can also serve as an inhibitor towards HAT enzymes[14]. It would also be interesting to 
determine whether meythyl groups added to acetylated H3(1-20) peptides can be a more potent 
inhibitor for Tip60.  
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APPENDICES 
Appendix A Mass Spectra for peptides  
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Appendix B: Graphs of data to find the rate for the best substrate  
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Appendix C: Graphs from radioactive inhibition assay  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graph 9: IC50 f CoA for fl-Tip60 Graph 10: IC50 of CoA for cat-Tip60 
 
Graph 52: IC50 of H3K4MeK14Br for 
cat-Tip60  
 
Graph 14: IC50 of H3K14Br for 
 cat-Tip60  
 
Graph 13: IC50 of H3K14Br for 
fl-Tip60  
 
Figure 11: IC50 of H3K4MeK14Br for 
fl-Tip60  
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Graph 16: IC50 of H3K9Me3K14SMe 
for cat-Tip60  
 
Graph 15: IC50 of H3K9Me3K14SMe 
for fl-Tip60  
Graph 6: IC50 of H3K4MeK9Me3K14CoA  
for fl-Tip60  
Graph 18: IC50 of H3K4MeK9Me3K14CoA 
for cat-Tip60  
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Graph 20: IC50 of H3K14SMe for  
fl-Tip60  
  
Graph 7: IC50 of H3K14SMe for  
fl-Tip60  
  
Graph 22: IC50 of H3K4MeK14CoA  
for cat-Tip60  
Graph 8: IC50 of H3K4MeK14CoA 
for fl-Tip60  
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IC50 = 5µM   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graph 9: IC50 of H3K4MeK14CoA 
for fl-Tip60  
Graph 24: IC50 of H3K4MeK14CoA 
for cat-Tip60  
Graph 10: IC50 of H3K9Me3K14CoA 
for fl-Tip60  
Graph 26: IC50 of H3K9Me3K14CoA 
for cat-Tip60  
IC50=2.5 µM  
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Graph 11: IC50 of H3K9Me3K14CoA 
for fl-Tip60  
Graph 28: IC50 of H3K9Me3K14CoA 
for cat-Tip60  
 
Graph 29: IC50 of H3K14CoA  
for fl-Tip60 
Graph 30: IC50 of H3K14CoA  
for cat-Tip60 
IC50=14.66 µM 
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